BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2014 5:15:00 PM | Browse: 813 | Download: 624
Publication Name World Journal of Gastroenterology
Manuscript ID 6864
Country India
Received
2013-10-29 16:29
Peer-Review Started
2013-10-30 19:39
To Make the First Decision
2013-11-21 18:57
Return for Revision
2013-11-22 10:39
Revised
2013-12-31 03:59
Second Decision
2014-01-20 18:55
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-01-20 19:28
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-03-10 21:48
Typeset the Manuscript
2014-04-25 19:05
Publish the Manuscript Online
2014-05-18 12:31
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Antitubercular therapy in patients with cirrhosis: Challenges and options
Manuscript Source Invited Manuscript
All Author List Naveen Kumar, Chandan Kumar Kedarisetty, Sachin Kumar, Vikas Khillan and Shiv Kumar Sarin
Funding Agency and Grant Number
Corresponding Author Dr. Shiv Kumar Sarin, MD, DM, DSc, FNA, Professor and Head, Department of Hepatology, Institute of Liver and Biliary Sciences, Vasant Kunj, Plot No.D-1, New Delhi 110070, India. shivsarin@gmail.com
Key Words Antitubercular therapy; Drug hepatotoxicity; Multidrug-resistant tuberculosis; Immune dysfunction
Core Tip Treatment of tuberculosis (TB) in patients with underlying cirrhosis is a challenge because of the compromised liver functions and high risk of hepatotoxicity. There is no consensus regarding the treatment and monitoring of TB in this group of patients. This paper reviews the differences in diagnosis, treatment, monitoring, hepatotoxicity and other issues in treatment of TB in patients with cirrhosis. Suggestions for treatment of TB in patients with different grades of cirrhosis, as well as monitoring guidelines, are provided. Finally, issues such as liver transplantation, multidrug-resistant TB and reactivation of TB by interferon are briefly reviewed.
Publish Date 2014-05-18 12:31
Citation Kumar N, Kedarisetty CK, Kumar S, Khillan V, Sarin SK. Anti-tubercular therapy in patients with cirrhosis: Challenges and options. World J Gastroenterol 2014; 20(19): 5760-5772
URL http://www.wjgnet.com/1007-9327/full/v20/i19/5760.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i19.5760
Full Article (PDF) WJG-20-5760.pdf
Full Article (Word) WJG-20-5760.doc
Manuscript File 6864-Review.docx
Answering Reviewers 6864-Answering reviews.pdf
Copyright License Agreement 6864-Copyright assignment.pdf
Peer-review Report 6864-Peer review(s).pdf
Scientific Editor Work List 6864-Scientific editor work list.doc